SHPA standards of practice for the provision of oral chemotherapy for the treatment of cancer

Journal of Pharmacy Practice and Research

Volumn 37, Issue 2, 2007, Pages 149-152

  Carrington, Christine ^a,b   Gilbar, Peter ^a   Wintraaken, Jeanette ^a  

^a SHPA Committee of Specialty Practice in Cancer Services   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT;

CANCER; CHEMOTHERAPY; DRUG LABELING; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; MEDICAL PRACTICE; PATIENT EDUCATION; PATIENT INFORMATION; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; STANDARD; TRAINING;

EID: 34547173157     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2007.tb00044.x     Document Type: Review

References (9)

1. SHPA Committee of Specialty Practice in Oncology. SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments. J Pharm Pract Res 2005; 35: 44-52.
2. SHPA Committee of Specialty Practice in Oncology. SHPA standards of practice for the provision of clinical oncology pharmacy services. J Pharm Pract Res 2002; 32: 115-118.
3. SHPA Committee of Specialty Practice in Clinical Pharmacy. SHPA standards of practice for clinical pharmacy. J Pharm Pract Res 2005; 35: 122-46.
4. SHPA Committee of Specialty Practice in Investigational Drugs. SHPA standards of practice for pharmacy investigational drugs services. J Pharm Pract Res 2006; 36: 46-53.
5. SHPA Committee of Specialty Practice in Oncology. Guidelines for counselling patients receiving drugs used in the treatment of neoplastic disease: a pharmacist's guide to advisory labels and patient information. Aust J Hosp Pharm 2001; 31: 51-5.
6. O'Neill VJ, Twelves CJ. Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer 2002; 87: 933-7.
7. Gilbar PJ, Carrington CV. Oral antineoplastic chemotherapy. J Pharm Pract Res 2005; 35: 195-8.
8. SHPA Consumer Medicines Working Party. SHPA standards of practice for the provision of consumer medicines information by pharmacists in hospitals. J Pharm Pract Res 2007; 37: 56-8.
9. Blower P, de Wit R, Goodin S, Aapro M. Drug-drug interactions in oncology: why they are important and can they be minimized? Crit Rev One Haemat 2005; 55: 117-42.